Today, we’re diving into some intriguing questions:
How can big pharmaceutical companies and small providers work together more effectively?
What hidden costs and inefficiencies are lurking in traditional outsourcing models?
And how can innovative solutions transform these dynamics?

I'm joined by Sheila Mahoney, a seasoned drug development expert with over 25 years of experience. Sheila introduces us to LifeSciHub, a platform designed to streamline contracting processes and enhance collaboration.

Together, we explore how LifeSciHub's approach not only improves cost-effectiveness but also ensures access to top-tier expertise.

Join us as we uncover new ways to optimize pharma collaborations for better outcomes.

In this exciting continuation of our series on digital transformation and innovation, we dive deeper into the crucial role of policies in driving successful change.

I’m joined once again by Chris Colangelo, who brings his extensive experience from working closely with IT and digital teams.

In this episode, we examine how companies often overlook strategic policies and the implications of build versus buy decisions. Chris shares his insights on aligning technology strategies with business objectives and navigating the complexities of organizational change.

Join us as we explore these essential aspects and provide actionable advice to help you lead effective digital transformation in your organization.

Here is Part 1 of this series:
https://theeffectivestatistician.com/digital-transformation-and-innovation-part-1/

Have you ever wondered why some digital transformation efforts fail miserably while others succeed brilliantly?

Are you curious about the key elements that can make or break innovation in your organization?

Today, I explore these questions with my former colleague and friend, Chris Colangelo. With extensive experience in digital transformation at Eli Lilly and Pfizer, Chris now leads his own consultancy, Colangelo Advisory Group.

In this episode, we uncover the critical mistakes to avoid and the strategies to embrace for successful innovation and transformation. From understanding the importance of mindset and managing emotions to navigating policies and effective communication, Chris shares invaluable insights for statisticians looking to drive meaningful change.

Let’s dive in and discover how to turn digital transformation challenges into opportunities!

Have you ever wondered how coaching can impact your career and success?

Are you curious about the differences between coaching and mentoring and how each can benefit you?

In this episode, I explore these questions with Alun Bedding, a seasoned statistician who has recently ventured into the world of coaching. I'm thrilled to welcome Alun back to the show. He shares his inspiring journey from taking leadership courses to launching his own coaching business. We explore the value of having a coach, the transformative power of effective coaching practices, and practical advice for enhancing your professional skills.

Whether you want to gain new perspectives or unlock your potential, this episode offers valuable insights for statisticians and professionals alike. Join us as we uncover how coaching can propel you toward greater achievements.

Are you curious about how benefit-risk assessments in healthcare evolve?

Do you wonder how patient preferences shape these evaluations?

Today, I speak with Tommi Tervonen, a leading expert in this field, to answer these questions and more. Tommi, the Chief Scientist at Kielo Research in Zurich, brings nearly two decades of experience in Multi-Criteria Decision Analysis (MCDA), patient preferences, and benefit-risk evaluations.

This episode sheds light on the past, present, and future of benefit-risk assessments and shows how incorporating patient input is transforming healthcare decisions. Join us as we dive deep into this fascinating topic and discover the importance of structured methodologies and patient-centric approaches in making informed healthcare choices.

Are you curious about how to leverage integrated evidence plans (IEPs) effectively?

Do you want to know how statisticians can meet the diverse evidence needs of stakeholders and ensure the right data is available at the right time?

In this second part of our series on IEPs, we continue our exploration with Jenny Devenport, focusing on the practical application and timing of IEPs. Last time, Jenny shared the foundational aspects and significance of IEPs. Today, we dive into the specifics:

Are you ready to explore the dynamic world of integrated evidence plans (IEPs) with me?

Have you ever wondered how pharmaceutical companies align their strategies across functions and geographies to support a product’s lifecycle?

In today's episode, I dive into the complexities and significance of IEPs. I’m excited to have the insightful Jenny Devenport with me, bringing her wealth of experience in medical affairs.

Together, we uncover what integrated evidence plans entail, why they are crucial for minimizing duplication of efforts, and how they cater to various stakeholders' needs. So, what exactly is an integrated evidence plan, and how can statisticians play a pivotal role in shaping them? Let's find out!

Are you ready to elevate your statistical skills and network with industry leaders?

Interested in presenting your research or learning from the best in the field?

Curious about how a virtual conference can enhance your professional growth?

This episode dives into the exciting details of the upcoming The Effective Statistician Conference, set to be our most interactive and diverse event yet.

Chantelle, a PhD candidate in health data science and a vital part of our team, shares a preview of the wide variety of topics and innovative features planned for this year. From methodological insights to leadership training, our conference covers a broad spectrum of subjects presented by esteemed speakers from various organizations.

Have you ever wondered how project management and collaboration between statisticians and clinical operations professionals impact clinical trials?

What challenges do they face, and how can they ensure high-quality, timely, and budget-conscious results?

Today, I’m thrilled to have Jessica Cordes with us. Jessica brings over 15 years of experience in clinical operations, particularly in oncology and cell and gene therapy. She founded her own consulting company, helping small to mid-sized companies with their clinical trial needs, and she launched a digital training academy to share her extensive knowledge.

In this episode, we dive into the intricacies of project management and collaboration, exploring how effective communication and detailed planning can significantly enhance the synergy between these crucial functions in the clinical research landscape. Tune in to gain valuable insights!

Have you ever wondered how we make crucial decisions in the early phases of clinical trials?

How can a Bayesian framework enhance these decisions?

Today, I talk with Audrey Yeo from Roche to answer these questions. Fresh from the PSI conference, Audrey, a seasoned statistical software engineer, introduces us to an innovative R package designed for early-phase clinical trials.

This tool promises to revolutionize decision-making with its Bayesian approach.

Join us as we explore the development, features, and impact of this groundbreaking tool, and discover the collaborative efforts that drive its evolution.